Yusung Kim, Ph.D., DABR

Peer-Reviewed Articles

1. Massock W, Kim Y, Dresner MA, Sun W, Caster J, Adams Q, Jespersen J, St-Aubin J. MRI guided High Dose Rate Gynecological Brachytherapy using an MR-Linac as an MR simulator: A Single Institutional Experience. Pract Radiat Oncol 14(1):70-79, 2024. e-Pub 2023. PMID: 37652344.
2. Choi BS, Yoo SK, Moon J, Chung SY, Oh J, Baek S, Kim Y, Chang JS, Kim H, Kim JS. Acute coronary event (ACE) prediction following breast radiotherapy by features extracted from 3D CT, dose, and cardiac structures. Med Phys 50(10):6409-6420, 2023. e-Pub 2023. PMID: 36974390.
3. Hopfensperger KM, Adams QE, Kim Y, Wu X, Xu W, Patwardhan K, Flynn RT. The population percentile allowance method for determining systematic spatial error tolerances for temporary intensity modulated brachytherapy. Med Phys 50(10):6469-6478, 2023. e-Pub 2023. PMID: 37643427.
4. Schmid MP, Lindegaard JC, Mahantshetty U, Tanderup K, Jürgenliemk-Schulz I, Haie-Meder C, Fokdal LU, Sturdza A, Hoskin P, Segedin B, Bruheim K, Huang F, Rai B, Cooper R, van der Steen-Banasik E, Van Limbergen E, Pieters BR, Petric P, Ramazanova D, Ristl R, Kannan S, Hawaldar R, Ecker S, Kirchheiner K, Tan LT, Nout R, Nesvacil N, de Leeuw A, Pötter R, Kirisits C, EMBRACE Collaborative Group. Risk Factors for Local Failure Following Chemoradiation and Magnetic Resonance Image-Guided Brachytherapy in Locally Advanced Cervical Cancer: Results From the EMBRACE-I Study. J Clin Oncol 41(10):1933-1942, 2023. e-Pub 2023. PMID: 36599120.
5. Prisciandaro J, Zoberi JE, Cohen G, Kim Y, Johnson P, Paulson E, Song W, Hwang KP, Erickson B, Beriwal S, Kirisits C, Mourtada F. Erratum: "AAPM task group report 303 endorsed by the ABS: MRI implementation in HDR brachytherapy-Considerations from simulation to treatment" https://doi.org/10.1002/mp.15713. Med Phys 50(2):1258, 2023. e-Pub 2022. PMID: 36316956.
6. Pati S, Baid U, Edwards B, Sheller M, Wang SH, Reina GA, Foley P, Gruzdev A, Karkada D, Davatzikos C, Sako C, Ghodasara S, Bilello M, Mohan S, Vollmuth P, Brugnara G, Preetha CJ, Sahm F, Maier-Hein K, Zenk M, Bendszus M, Wick W, Calabrese E, Rudie J, Villanueva-Meyer J, Cha S, Ingalhalikar M, Jadhav M, Pandey U, Saini J, Garrett J, Larson M, Jeraj R, Currie S, Frood R, Fatania K, Huang RY, Chang K, Balaña C, Capellades J, Puig J, Trenkler J, Pichler J, Necker G, Haunschmidt A, Meckel S, Shukla G, Liem S, Alexander GS, Lombardo J, Palmer JD, Flanders AE, Dicker AP, Sair HI, Jones CK, Venkataraman A, Jiang M, So TY, Chen C, Heng PA, Dou Q, Kozubek M, Lux F, Michálek J, Matula P, Kerkovský M, Koprivová T, Dostál M, Vybíhal V, Vogelbaum MA, Mitchell JR, Farinhas J, Maldjian JA, Yogananda CGB, Pinho MC, Reddy D, Holcomb J, Wagner BC, Ellingson BM, Cloughesy TF, Raymond C, Oughourlian T, Hagiwara A, Wang C, To MS, Bhardwaj S, Chong C, Agzarian M, Falcão AX, Martins SB, Teixeira BCA, Sprenger F, Menotti D, Lucio DR, LaMontagne P, Marcus D, Wiestler B, Kofler F, Ezhov I, Metz M, Jain R, Lee M, Lui YW, McKinley R, Slotboom J, Radojewski P, Meier R, Wiest R, Murcia D, Fu E, Haas R, Thompson J, Ormond DR, Badve C, Sloan AE, Vadmal V, Waite K, Colen RR, Pei L, Ak M, Srinivasan A, Bapuraj JR, Rao A, Wang N, Yoshiaki O, Moritani T, Turk S, Lee J, Prabhudesai S, Morón F, Mandel J, Kamnitsas K, Glocker B, Dixon LVM, Williams M, Zampakis P, Panagiotopoulos V, Tsiganos P, Alexiou S, Haliassos I, Zacharaki EI, Moustakas K, Kalogeropoulou C, Kardamakis DM, Choi YS, Lee SK, Chang JH, Ahn SS, Luo B, Poisson L, Wen N, Tiwari P, Verma R, Bareja R, Yadav I, Chen J, Kumar N, Smits M, van der Voort SR, Alafandi A, Incekara F, Wijnenga MMJ, Kapsas G, Gahrmann R, Schouten JW, Dubbink HJ, Vincent AJPE, van den Bent MJ, French PJ, Klein S, Yuan Y, Sharma S, Tseng TC, Adabi S, Niclou SP, Keunen O, Hau AC, Vallières M, Fortin D, Lepage M, Landman B, Ramadass K, Xu K, Chotai S, Chambless LB, Mistry. Author Correction: Federated learning enables big data for rare cancer boundary detection. Nat Commun 14(1):436, 2023. e-Pub 2023. PMID: 36702828.
7. Gainey JC, He Y, Zhu R, Baek SS, Wu X, Buatti JM, Allen BG, Smith BJ, Kim Y. Predictive power of deep-learning segmentation based prognostication model in non-small cell lung cancer. Front Oncol 13:868471, 2023. e-Pub 2023. PMID: 37081986.
8. Pati S, Baid U, Edwards B, Sheller M, Wang SH, Reina GA, Foley P, Gruzdev A, Karkada D, Davatzikos C, Sako C, Ghodasara S, Bilello M, Mohan S, Vollmuth P, Brugnara G, Preetha CJ, Sahm F, Maier-Hein K, Zenk M, Bendszus M, Wick W, Calabrese E, Rudie J, Villanueva-Meyer J, Cha S, Ingalhalikar M, Jadhav M, Pandey U, Saini J, Garrett J, Larson M, Jeraj R, Currie S, Frood R, Fatania K, Huang RY, Chang K, Balaña C, Capellades J, Puig J, Trenkler J, Pichler J, Necker G, Haunschmidt A, Meckel S, Shukla G, Liem S, Alexander GS, Lombardo J, Palmer JD, Flanders AE, Dicker AP, Sair HI, Jones CK, Venkataraman A, Jiang M, So TY, Chen C, Heng PA, Dou Q, Kozubek M, Lux F, Michálek J, Matula P, Kerkovský M, Koprivová T, Dostál M, Vybíhal V, Vogelbaum MA, Mitchell JR, Farinhas J, Maldjian JA, Yogananda CGB, Pinho MC, Reddy D, Holcomb J, Wagner BC, Ellingson BM, Cloughesy TF, Raymond C, Oughourlian T, Hagiwara A, Wang C, To MS, Bhardwaj S, Chong C, Agzarian M, Falcão AX, Martins SB, Teixeira BCA, Sprenger F, Menotti D, Lucio DR, LaMontagne P, Marcus D, Wiestler B, Kofler F, Ezhov I, Metz M, Jain R, Lee M, Lui YW, McKinley R, Slotboom J, Radojewski P, Meier R, Wiest R, Murcia D, Fu E, Haas R, Thompson J, Ormond DR, Badve C, Sloan AE, Vadmal V, Waite K, Colen RR, Pei L, Ak M, Srinivasan A, Bapuraj JR, Rao A, Wang N, Yoshiaki O, Moritani T, Turk S, Lee J, Prabhudesai S, Morón F, Mandel J, Kamnitsas K, Glocker B, Dixon LVM, Williams M, Zampakis P, Panagiotopoulos V, Tsiganos P, Alexiou S, Haliassos I, Zacharaki EI, Moustakas K, Kalogeropoulou C, Kardamakis DM, Choi YS, Lee SK, Chang JH, Ahn SS, Luo B, Poisson L, Wen N, Tiwari P, Verma R, Bareja R, Yadav I, Chen J, Kumar N, Smits M, van der Voort SR, Alafandi A, Incekara F, Wijnenga MMJ, Kapsas G, Gahrmann R, Schouten JW, Dubbink HJ, Vincent AJPE, van den Bent MJ, French PJ, Klein S, Yuan Y, Sharma S, Tseng TC, Adabi S, Niclou SP, Keunen O, Hau AC, Vallières M, Fortin D, Lepage M, Landman B, Ramadass K, Xu K, Chotai S, Chambless LB, Mistry. Federated learning enables big data for rare cancer boundary detection. Nat Commun 13(1):7346, 2022. e-Pub 2022. PMID: 36470898.
9. Prisciandaro J, Zoberi JE, Cohen G, Kim Y, Johnson P, Paulson E, Song W, Hwang KP, Erickson B, Beriwal S, Kirisits C, Mourtada F. AAPM task group report 303 endorsed by the ABS: MRI implementation in HDR brachytherapy-Considerations from simulation to treatment. Med Phys 49(8):e983-e1023, 2022. e-Pub 2022. PMID: 35662032.
10. Waldron TJ, Allen BG, Pennington E, Boldt HC, Kim Y. Radiobiological evaluation of organs at risk for electronic high-dose-rate brachytherapy in uveal melanoma: a radiobiological modeling study. J Contemp Brachytherapy 13(5):563-574, 2021. e-Pub 2021. PMID: 34759981.
11. Yi J, Adams QE, Hopfensperger KM, Flynn RT, Kim, Y, Buatti JM, Xu, W. Wu, X. Optimal Needle Placement for Prostate Rotating-Shield Brachytherapy (RSBT), 2021.
12. Smith BR, Strand SA, Dunkerley D, Flynn RT, Besemer AE, Kos JD, Caster JM, Wagner BS, Kim Y. Implementation of a real-time, ultrasound-guided prostate HDR brachytherapy program. J Appl Clin Med Phys 22(9):189-214, 2021. e-Pub 2021. PMID: 34312999.
13. Pötter R, Tanderup K, Schmid MP, Jürgenliemk-Schulz I, Haie-Meder C, Fokdal LU, Sturdza AE, Hoskin P, Mahantshetty U, Segedin B, Bruheim K, Huang F, Rai B, Cooper R, van der Steen-Banasik E, Van Limbergen E, Pieters BR, Tan LT, Nout RA, De Leeuw AAC, Ristl R, Petric P, Nesvacil N, Kirchheiner K, Kirisits C, Lindegaard JC, EMBRACE Collaborative Group. MRI-guided adaptive brachytherapy in locally advanced cervical cancer (EMBRACE-I): a multicentre prospective cohort study. Lancet Oncol 22(4):538-547, 2021. PMID: 33794207.
14. Adams Q, Hopfensperger KM, Kim Y, Wu X, Flynn RT. 169 Yb-based rotating shield brachytherapy for prostate cancer. Med Phys 47(12):6430-6439, 2020. e-Pub 2020. PMID: 33051866.
15. Hopfensperger KM, Adams Q, Kim Y, Wu X, Xu W, Patwardhan K, Thammavong B, Caster J, Flynn RT. Needle-free cervical cancer treatment using helical multishield intracavitary rotating shield brachytherapy with the 169 Yb Isotope. Med Phys 47(5):2061-2071, 2020. e-Pub 2020. PMID: 32073669.
16. Cunha JAM, Flynn R, Bélanger C, Callaghan C, Kim Y, Jia X, Chen Z, Beaulieu L. Brachytherapy Future Directions. Semin Radiat Oncol 30(1):94-106, 2020. PMID: 31727305.
17. Callaghan CM, Adams Q, Flynn RT, Wu X, Xu W, Kim Y. Systematic Review of Intensity-Modulated Brachytherapy (IMBT): Static and Dynamic Techniques. Int J Radiat Oncol Biol Phys 105(1):206-221, 2019. e-Pub 2019. PMID: 31026556.
18. Flynn RT, Adams QE, Hopfensperger KM, Wu X, Xu W, Kim Y. Efficient 169 Yb high-dose-rate brachytherapy source production using reactivation. Med Phys 46(7):2935-2943, 2019. e-Pub 2019. PMID: 31054163.
19. Snyder JE, Willett AB, Sun W, Kim Y. Is SBRT Boost Feasible for PET Positive Lymph Nodes for Cervical Cancer? Evaluation using Tumor Control Probability and QUANTEC Criteria. Pract Radiat Oncol 9(2):e156-e163, 2019. e-Pub 2018. PMID: 30415074.
20. Zhong Z, Kim Y, Plichta K, Allen BG, Zhou L, Buatti J, Wu X. Simultaneous cosegmentation of tumors in PET-CT images using deep fully convolutional networks. Med Phys 46(2):619-633, 2019. e-Pub 2019. PMID: 30537103.
21. Adams Q, Hopfensperger KM, Kim Y, Wu X, Xu W, Shukla H, McGee J, Caster JM, Flynn RT. Effectiveness of Rotating Shield Brachytherapy for Prostate Cancer Dose Escalation and Urethral Sparing. Int J Radiat Oncol Biol Phys 102(5):1543-1550, 2018. e-Pub 2018. PMID: 30092333.
22. Kim Y, Cabel K, Sun W. Does the apex optimization line matter for single-channel vaginal cylinder brachytherapy planning?. J Appl Clin Med Phys 19(4):307-312, 2018. e-Pub 2018. PMID: 29766643.
23. Zhong Z, Kim Y, Zhou L, Plichta K, Allen B, Buatti J, Wu X. IMPROVING TUMOR CO-SEGMENTATION ON PET-CT IMAGES WITH 3D CO-MATTING. Proc IEEE Int Symp Biomed Imaging 2018:224-227, 2018. e-Pub 2018. PMID: 31762933.
24. Zhong Z, Kim Y, Zhou L, Plichta K, Allen B, Buatti J, Wu X. 3D FULLY CONVOLUTIONAL NETWORKS FOR CO-SEGMENTATION OF TUMORS ON PET-CT IMAGES. Proc IEEE Int Symp Biomed Imaging 2018:228-231, 2018. e-Pub 2018. PMID: 31772717.
25. Gelover E, Katherine C, Mart C, Sun W, Kim Y. Patient's specific integration of OAR doses (D2 cc) from EBRT and 3D image-guided brachytherapy for cervical cancer. J Appl Clin Med Phys 19(2):83-92, 2018. e-Pub 2018. PMID: 29349933.
26. Andrew M, Kim Y, Ginader T, Smith BJ, Sun W, Wang D. Reduction of applicator displacement in MR/CT-guided cervical cancer HDR brachytherapy by the use of patient hover transport system. J Contemp Brachytherapy 10(1):85-90, 2018. e-Pub 2018. PMID: 29619060.
27. Dadkhah H, Hopfensperger KM, Kim Y, Wu X, Flynn RT. Multisource Rotating Shield Brachytherapy Apparatus for Prostate Cancer. Int J Radiat Oncol Biol Phys 99(3):719-728, 2017. e-Pub 2017. PMID: 28843372.
28. Cho M, Wu X, Dadkhah H, Yi J, Flynn RT, Kim Y, Xu W. Fast dose optimization for rotating shield brachytherapy. Med Phys 44(10):5384-5392, 2017. e-Pub 2017. PMID: 28744870.
29. Zhong Z, Kim Y, Buatti J, Wu X. 3D Alpha Matting Based Co-segmentation of Tumors on PET-CT Images. Mol Imaging Reconstr Anal Mov Body Organs Stroke Imaging Treat (2017) 10555:31-42, 2017. e-Pub 2017. PMID: 31799515.
30. Kim Y , Patwardhan KA, Beichel RR, Smith BJ, Mart C, Plichta KA, Chang T, Sonka M, Graham MM, Magnotta V, Casavant T, Junyi Xia , Buatti JM. Development of a radiobiological evaluation tool to assess the expected clinical impacts of contouring accuracy between manual and semi-automated segmentation algorithms. Annu Int Conf IEEE Eng Med Biol Soc 2017:3409-3412, 2017. PMID: 29060629.
31. Wears B, Mohiuddin I, Flynn R, Kim Y, Waldron T, Allen B, Junyi Xia. Design of a compact collimator and 3D imaging system for a scanning beam low-energy intraoperative radiation therapy system for pancreatic cancer. Annu Int Conf IEEE Eng Med Biol Soc 2017:4325-4328, 2017. PMID: 29060854.
32. Kim Y, Modrick JM, Pennington EC, Kim Y. Commissioning of a 3D image-based treatment planning system for high-dose-rate brachytherapy of cervical cancer. J Appl Clin Med Phys 17(2):405-426, 2016. e-Pub 2016. PMID: 27074463.
33. Bou-Zeid W., Bauer C., Kim Y, Beichel R., Sun W., Waldron T., Xia J. Clinical Validation of a Real-time Applicator Position Monitoring System for Gynecologic Intracavitary Brachytherapy. Biomedical Physics & Engineering Express, 2016.
34. Dadkhah H, Kim Y, Wu X, Flynn RT. Multihelix rotating shield brachytherapy for cervical cancer. Med Phys 42(11):6579-88, 2015. PMID: 26520749.
35. Liu Y, Flynn RT, Kim Y, Dadkhah H, Bhatia SK, Buatti JM, Xu W, Wu X. Paddle-based rotating-shield brachytherapy. Med Phys 42(10):5992-6003, 2015. PMID: 26429274.
36. Liu Y, Flynn RT, Kim Y, Wu X. Asymmetric dose-volume optimization with smoothness control for rotating-shield brachytherapy. Med Phys 41(11):111709, 2014. PMID: 25370623.
37. Zhang W, Bhatia SK, Sun W, Modrick JM, Kim Y. Bladder and rectum dose estimations on digitized radiographs for vaginal brachytherapy after hysterectomy. J Appl Clin Med Phys 15(6):5033, 2014. e-Pub 2014. PMID: 25493529.
38. Siochi RA, Kim Y, Bhatia S. Tumor control probability reduction in gated radiotherapy of non-small cell lung cancers: a feasibility study. J Appl Clin Med Phys 16(1):4444, 2014. e-Pub 2014. PMID: 25679148.
39. Adams QE, Xu J, Breitbach EK, Li X, Enger SA, Rockey WR, Kim Y, Wu X, Flynn RT. Interstitial rotating shield brachytherapy for prostate cancer. Med Phys 41(5):051703, 2014. PMID: 24784369.
40. Kim Y, Seol DR, Mohapatra S, Sunderland JJ, Schultz MK, Domann FE, Lim TH. Locally targeted delivery of a micron-size radiation therapy source using temperature-sensitive hydrogel. Int J Radiat Oncol Biol Phys 88(5):1142-7, 2014. e-Pub 2014. PMID: 24495593.
41. Xia J, Waldron T, Kim Y. A real-time applicator position monitoring system for gynecologic intracavitary brachytherapy. Med Phys 41(1):011703, 2014. PMID: 24387495.
42. Liu Y, Flynn RT, Kim Y, Yang W, Wu X. Dynamic rotating-shield brachytherapy. Med Phys 40(12):121703, 2013. PMID: 24320489.
43. Schindel J, Zhang W, Bhatia SK, Sun W, Kim Y. Dosimetric impacts of applicator displacements and applicator reconstruction-uncertainties on 3D image-guided brachytherapy for cervical cancer. J Contemp Brachytherapy 5(4):250-7, 2013. e-Pub 2013. PMID: 24474977.
44. Yang W, Kim Y, Wu X, Song Q, Liu Y, Bhatia SK, Sun W, Flynn RT. Rotating-shield brachytherapy for cervical cancer. Phys Med Biol 58(11):3931-41, 2013. e-Pub 2013. PMID: 23680601.
45. Anderson JW, Xia J, Flynn RT, Modrick JM, Bhatia SK, Jacobson GM, Kim Y. High resolution (3 Tesla) MRI-guided conformal brachytherapy for cervical cancer: consequences of different high-risk CTV sizes. J Contemp Brachytherapy 5(2):101-9, 2013. e-Pub 2013. PMID: 23878555.
46. Schindel J, Muruganandham M, Pigge FC, Anderson J, Kim Y. Magnetic resonance imaging (MRI) markers for MRI-guided high-dose-rate brachytherapy: novel marker-flange for cervical cancer and marker catheters for prostate cancer. Int J Radiat Oncol Biol Phys 86(2):387-93, 2013. e-Pub 2013. PMID: 23433797.
47. Liu Y, Flynn RT, Yang W, Kim Y, Bhatia SK, Sun W, Wu X. Rapid emission angle selection for rotating-shield brachytherapy. Med Phys 40(5):051720, 2013. PMID: 23635268.
48. Rockey WM, Bhatia SK, Jacobson GM, Kim Y. The dosimetric impact of vaginal balloon-packing on intracavitary high-dose-rate brachytherapy for gynecological cancer. J Contemp Brachytherapy 5(1):17-22, 2013. e-Pub 2013. PMID: 23634151.
49. Dou X, Kim Y, Bayouth JE, Buatti JM, Wu X. Optimal field-splitting algorithm in intensity-modulated radiotherapy: evaluations using head-and-neck and female pelvic IMRT cases. Med Dosim 38(1):12-7, 2013. e-Pub 2012. PMID: 22835649.
50. Anderson J, Huang Y, Kim Y. Dosimetric impact of point A definition on high-dose-rate brachytherapy for cervical cancer: evaluations on conventional point A and MRI-guided, conformal plans. J Contemp Brachytherapy 4(4):241-6, 2012. e-Pub 2012. PMID: 23378854.
51. Yang W, Kim Y, Liu Y, Wu X, Flynn R. SU-E-T-547: Rotating Shield Brachytherapy (RSBT) for Cervical Cancer. Med Phys 39(6Part18):3831, 2012. PMID: 28518488.
52. Sun W, Bhatia SK, Jacobson GM, Flynn RT, Kim Y. Target volume changes through high-dose-rate brachytherapy for cervical cancer when evaluated on high resolution (3.0 Tesla) magnetic resonance imaging. Pract Radiat Oncol 2(4):e101-e106, 2012. e-Pub 2012. PMID: 24674171.
53. Hyer DE, Sheybani A, Jacobson GM, Kim Y. The dosimetric impact of heterogeneity corrections in high-dose-rate ¹?²Ir brachytherapy for cervical cancer: Investigation of both conventional Point-A and volume-optimized plans. Brachytherapy 11(6):515-20, 2012. e-Pub 2012. PMID: 22386723.
54. Kim Y, Muruganandham M, Modrick JM, Bayouth JE. Evaluation of artifacts and distortions of titanium applicators on 3.0-Tesla MRI: feasibility of titanium applicators in MRI-guided brachytherapy for gynecological cancer. Int J Radiat Oncol Biol Phys 80(3):947-55, 2011. e-Pub 2010. PMID: 20934275.
55. Kim Y, Tomé WA. On the impact of functional imaging accuracy on selective boosting IMRT. Phys Med 25(1):12-24, 2009. e-Pub 2008. PMID: 18206411.
56. Kim Y , Tome WA. Is it beneficial to selectively boost high-risk tumor subvolumes? A comparison of selectively boosting high-risk tumor subvolumes versus homogeneous dose escalation of the entire tumor based on equivalent EUD plans. Acta Oncol 47(5):906-16, 2008. PMID: 18568486.
57. Kim Y , Tomé WA. On Voxel based Iso-Tumor Control Probabilty and Iso-Complication Maps for Selective Boosting and Selective Avoidance Intensity Modulated Radiotherapy. Imaging Decis (Berl) 12(1):42-50, 2008. PMID: 21151734.
58. Kim Y , Tomé W. Optimization of radiotherapy using biological parameters. Cancer Treat Res 139:257-78, 2008. PMID: 18236720.
59. Kim Y , Tomé WA. On the radiobiological impact of metal artifacts in head-and-neck IMRT in terms of tumor control probability (TCP) and normal tissue complication probability (NTCP). Med Biol Eng Comput 45(11):1045-51, 2007. e-Pub 2007. PMID: 17574487.
60. Kim Y, Tomé WA.. Is theragnostic image-guided, selective boosting IMRT more effective than “agnostic” boosting IMRT?: A comparison based on equivalent EUD plans. Radiother Oncol, 2007.
61. Kim Y , Tomé WA. Risk-adaptive optimization: selective boosting of high-risk tumor subvolumes. Int J Radiat Oncol Biol Phys 66(5):1528-42, 2006. PMID: 17126211.
62. Kim Y, Tomé WA, Bal M, McNutt TR, Spies L. The impact of dental metal artifacts on head and neck IMRT dose distributions. Radiother Oncol 79(2):198-202, 2006. e-Pub 2006. PMID: 16677729.
63. Kim Y, Tomé WA, Bali M, McNutt T, Spies L. Dosimetric impact of dental metal artifact present in head and neck CT data sets on IMRT dose distributions. Radiother Oncol:S177, 2005.

Invited Articles

1. Kim Y, Rockey W. High-Dose-Rate Brachytherapy for Localized Prostate Cancer: An Opportunity for Improvement over Intensity-Modulated Radiotherapy. Austin Journal of Radiation Therapy and Cancer 2(2):1027-1037, 2015.
2. Li H, Bai J, Wu X, Bhatia SK, Hejleh TA, Sun W, Tennapel MJ, Menda Y, Mart CJ, McGuire SM, Flynn RT, Bayouth JE, Buatti JM, Kim Y. Semi-Automatic, Co-Segmentation using PET-CT for Lung Tumor. Austin J Cancer Clin Res, 2014.

Book Chapters

1. Kim Y, Tomé WA.. In: Radiation Oncology Advances, p257-278, 2007.

Books (edited and written)

1. Kim Y, Tomé WA. Dose-painting IMRT optimization using biological parameters. In: Acta Oncol. 8, 1374-84, 2010.